glp-1 studies near me Market Overview: Agonists and the Obesity Market | Blog GLP-1 agonists and changes in

New research suggests GLP-1 medications may influence osteoarthritis beyond weight loss

Every claim is backed by citations from PubMed-indexed medical journals

Learn how to start and convert your appropriate type 1 diabetes and type 2 diabetes patients over 1 year of age to once-daily Tresiba (insulin degludec)

IQVIA notes six big shifts in medicines use in 2023: Growing use of immunology treatments up 60% from 2019 with treatment of Crohns disease and psoriasis up 26% and 15%, respectively Rising use of novel obesity drugs which is the GLP-1 story Ill relate to the next graphic, below

This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)

GLP-1 Drugs and the Food Industry: A Shift We Cant Ignore I recently came across this topic and felt like sharing it here